Pixee Medical Granted CE Mark for Knee+ NexSight

Pixee Medical received approval under the CE Mark for the Knee+ NexSight augmented reality-based solution for total knee arthroplasty.  The first procedures have already been performed in Europe.

Designed for suitability in high-throughput operating rooms, Knee+ NexSight projects a virtual screen directly into the surgeon’s field of view and incorporates voice command to enhance user experience. Lighter and more compact than the previous generation, the system requires no robot, no dedicated console, and no single-use disposables.

Knee+ NexSight is engineered to deliver robotic-level accuracy while preserving efficiency, cost-effectiveness, and simplicity. The instrumentation is less invasive, can reduce blood loss, and integrates seamlessly into existing surgical workflows without adding operative time compared to conventional techniques.

Knee+ NexSight is fully compatible with most primary knee implants and supports personalized alignment strategies, including kinematic alignment. Its software architecture is also designed for connectivity, enabling secure integration with third-party digital solutions and remote software updates as operating rooms become increasingly data-driven.

“Knee+ NexSight is not just an incremental update; it is a new way to think about AR guidance in high-volume environments,” said Sébastien Henry, CEO of Pixee Medical. “It brings the accuracy of a robot in the form factor of a pair of glasses – without heavy infrastructure, without pre-operative imaging, and without disposables. We now look forward to FDA clearance so we can support the first procedures in the United States and expand access to this technology,” said Sébastien Henry, CEO of Pixee Medical.

Source: Pixee Medical